Sucrose
CAS: 57-50-1
Category: Carbohydrates
| Purity | FCC Food Grade ≥99.9%, USP/NF Grade, Reagent Grade ≥99.5% |
| Molecular Formula | C12H22O11 |
| Molecular Weight | 342.3 |
| Appearance | colorless sweet-tasting crystals or white crystalline powder |
| Packaging | 25kg/woven bag with an inner plastic coating or 50kg/fiber drum. |
| Testing Indicators | Appearance — Visual inspection; Specific rotation — Polarimetry; Identification — IR, Reducing sugars test; Purity — HPLC; Color of solution — Spectrophotometry; Heavy metals — ICP-MS; Loss on drying — Gravimetry; Microbial limits — Pour plate; Sulfite — Colorimetry. |
| Storage Notes | Store in a tightly closed container in a cool, dry, and well-ventilated place, as it is hygroscopic. |
| Lead Time | 10 days |
Related Products
D-(+)-Trehalose dihydrate
6138-23-4Purity: FCC Food Grade ≥99%, USP/NF Grade, Reagent Grade ≥98.5%
D-arabinopyranose
28697-53-2Purity: Reagent Grade ≥98%, Pharmaceutical Grade ≥99%, Biochemical Grade ≥99%, Technical Grade ≥95%.
Migalastat (hydrochloride)
75172-81-5Purity: Pharmaceutical Grade ≥99%, API Grade ≥99.5%, Oral Grade ≥99%, Technical Grade ≥98%.
D-Allopyranose
2595-97-3Purity: Research Grade ≥98%, Analytical Standard Grade ≥99%, High-Purity Grade ≥98%, Biochemical Grade ≥97%
Related Patents
Use of polyphenol containing sugar cane extracts for preventing, improving or treating a skin condition
US12370232B2The present disclosure is in the field of the prevention, improvement or treatment of skin conditions, for example skin conditions associated with skin aging and/or skin pigmentation and/or wound heal...
Enzymatically polymerized gelling dextrans
US12173091B2Compositions are disclosed herein comprising dextran that comprises (i) 87-93 wt % glucose linked at positions 1 and 6; (ii) 0.1-1.2 wt % glucose linked at positions 1 and 3; (iii) 0.1-0.7 wt % glucos...
Method for freeze-drying lipid nanoparticles
JP7839148B2This disclosure relates to the field of pharmaceutical manufacturing and products. More specifically, this disclosure relates to methods for preparing lipid nanoparticle-encapsulated nucleic acid comp...
Processes for the Manufacture and Use of Pancreatin
US20200299669A1A process for the manufacture and use of pancreatin in which the concentration of one or more biological contaminants is reduced, such as viruses and/or bacteria, through heating the pancreatin at a t...
Hederagenin compound H-X with anti-lung cancer effect and preparation method and application thereof
CN110964078BThe invention provides an hederagenin compound H-X with an anti-tumor effect, a preparation method and application thereof, and the structural general formula 1 is as follows. Most of the derivatives ...